Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 26 for “"Anti-TNFa"”.
-
Anti-TNFa treatment in rheumatoid arthritis
Contains fulltext : 19044.pdf (Publisher’s version ) (Open Access)
-
Η συμβολή του Infliximab (anti-TNFa) ως αντιουλωτικού παράγοντα στην επέμβαση του γλαυκώματος
… apoptosis. Infliximab is a chimeric monoclonal antibody that binds to both soluble and transmembrane proinflammatory cytokine TNF-α. We hypothesized that blocking TNF-a with Infliximab would reduce both inflammation and fibrosis post glaucoma filtration surgery and consequently enhance bleb …
-
Εκτίμηση φλεγμονώδους φορτίου, ενδοθηλιακής και καρδιακής λειτουργίας πριν και μετά από χειρουργική και φαρμακευτική παρέμβαση σε ασθενείς με ιδιοπαθείς φλεγμονώδεις εντερικές νόσους
… after intervention (surgical (35 patients) or anti-TNFa treatment (25 patients)). IBD severity, using Mayo score, Harvey–Bradshaw Index (HBI) and biomarkers, was correlated with cardiovascular markers. At baseline, the disease severity, the white blood cells (WBC) values and the reducing power …
-
Η μελέτη της επίπτωσης των ψυχιατρικών νοσημάτων με ειδικές διαγνωστικές μεθόδους στη ψωρίαση
… ασθενείς με μέτρια - σοβαρή ψωρίαση υπό αγωγή με anti-TNFa/anti-IL12/23, σεκουκινουμάμπη ή απρεμιλάστη. Μέθοδοι: Στη μελέτη συμπεριλήφθησαν 242 ασθενείς, οι οποίοι παρακολουθούνταν στο ειδικό ιατρείο ψωρίασης της Β’ Πανεπιστημιακής Κλινικής Δερματικών και Αφροδίσιων Νόσων του Π.Γ.Ν. Αττικόν, του …
-
Προγνωστικοί παράγοντες για μη-ανταπόκριση και απώλεια της ανταπόκρισης σε ασθενείς με φλεγμονώδη νόσο του εντέρου που λαμβάνουν anti-TNF θεραπεία
Objectives: A substantial number of Crohn’s disease (CD) or ulcerative colitis (UC) patients lose response to anti-TNFa and therapy needs to be intensified. We aimed to prospectively determine predictors and frequency of anti-TNFa non-response or loss of response and therefore the need for dose …
-
Μακροχρόνια χορήγηση βιολογικών παραγόντων και αναπνευστική λειτουργία στην αγκυλοποιητική σπονδυλοαρθρίτιδα
… correlates with BASFI and its response to anti-TNFa treatment is significant from the first 3 months lasting for at least 1 year. The relative contribution of the ribcage and abdomen to lung volume displacement during speech production correlates with the relative contribution during quiet …
-
T cell responses to putative antigens and downregulation of cytokineproduction by infliximab in ankylosing spondylitis patients
… an immune response against an unknown putative antigen could play a crucial role. T cell responses to antigens derived from bacteria such as klebsiella or to autoantigens derived from the cartilage such as proteoglycan have been tested, but no convincing evidence for their involvement in the …
-
Einfluss von UVB-Strahlung auf die Antigen-präsentierende Funktion Dendritischer Zellen - Apoptoseinduktion bei T-Zellen
… nicht von Wildtyp-TZ. Auch die Zugabe eines anti-TNFa-AK zu den Kokulturen hob die UVB-induzierte Proliferationshemmung der TZ nicht auf. Dadurch konnte eine Bedeutung zweier wichtiger Signaltransduktionsswege des Immunsystems, nämlich über Fas und über TNF, ausgeschlossen werden. Die …
-
The partner as resource or restriction? : labour market careers of husbands and wives and the consequences for inequality between couples
… studies, using data collected on TNFa blocking agents in rheumatoid arthritis. First, the need for and value of information from daily clinical practice was researched. Together, the results of Chapters 3, 4 and 5 illustrated that treatment of RA patients with anti-TNFa blocking …
-
Evaluation of new drugs in daily clinical practice: anti-TNF alpha in rheumatoid arthritis patients.
… studies, using data collected on TNFa blocking agents in rheumatoid arthritis. First, the need for and value of information from daily clinical practice was researched. Together, the results of Chapters 3, 4 and 5 illustrated that treatment of RA patients with anti-TNFa blocking …
-
The production and characterization of a putative anti-idiotypic antibody to tumor necrosis factor-α
Tumor necrosis factor-a (TNFa) is primarily a macrophagederived cytokine. TNFa, in vitro, kills or inhibits growth of approximately one third of surveyed transformed cell lines dincluding the L929 and WEHI 164 murine fibrosarcoma cell lines. Very little is known about the mechanisms of TNFa action. …
-
Role of inflammation and endothelial dysfunction of coronary arterioles in type 2 diabetes
… associated withdiabetes. The interaction between TNFa and monocyte chemoattractant protein-1 (MCP-1) may contribute to the evolution of vascular inflammation and endothelial dysfunctionin coronary arterioles in type 2 diabetes. To test this hypothesis, endothelium-dependent(ACh) and –independent …
-
Μελέτη εξωεντερικών εκδηλώσεων των ασθενών με ιδιοπαθή φλεγμονώδη πάθηση των εντέρων στη Βορειοδυτική Ελλάδα
… oculardisorders that need a special attention. Anti-TNFa medications represent the first effective biologictherapy for IBD that has largely revolutionized treatment.Aim: The aim of the current study was the recording of the ocular disorders in patients with IBD treatedwith methotrexate. Also …
-
Metabolomic profiling in inflammatory bowel disease
… and to determine the effect of medical (anti-TNFa agents) and surgical treatment on the metabolome. Methods A metabolomics approach was undertaken. Serum and urine sample sets were collected from a total of 41 patients with ulcerative colitis, 43 patients with Crohn’s disease, and 62 …
-
Development of holistic analytical methods for disease biomarker discovery and the study of drug efficasy in autoimmune disease
… vivo model TG197 that closely mimics the human TNFa RA expression that could potentially help the translation of the finding into the clinic. For this purpose a targeted LC-MS based analytical platform was successfully developed and validated using an ion pair chromatographic separation that …
-
Περιτοναϊκές συμφύσεις: στοιχεία παθοφυσιολογίας, πειραματικά μοντέλα και νεότεροι θεραπευτικοί στόχοι
… δράση του παράγοντα νέκρωσης των όγκων-α (anti-TNFa), ο αυξητικός παράγοντας των κερατινοκυττάρων (Keratinocyte growth factor) σε συνδυασμό με Sodium Hyalurinate Gel, η ρεσβερατρόλη (φυτικό συστατικό που ανήκει στην κατηγορία των φυτοαλεξινών με βασική δομή στιλβενίων), η μεταλλαγμένη …
-
Tuberculosis, Anaemia and Erythropoietin: a study evaluating the role of erythropoietin in the pathophysiology of the anaemia of tuberculosis
… the effect of tumour necrosis factor alpha (TNFa) produced by activated macrophages in PTB patients on Epo production in vitro. Furthermore, the mechanism involved in Epo gene expression was investigated. Haematological and biochemical parameters (including serum iron and Epo) were I studied …
-
Φαρμακογενωμική ανάλυση ασθενών με ιδιοπαθή φλεγμονώδη νόσο του εντέρου (ΙΦΝΕ) και συσχέτιση με ανταπόκριση στους αντι-TNF παράγοντες
… IBD include aminosalicylates, corticosteroids, antibiotics, immunosuppressants, and in recent years, biological therapies which include the anti-TNF agents. However, because of the great heterogeneity in patients’ response, there is need to highlight markers that are able to predict this …
-
Η επίδραση της θεραπείας με ανταγωνιστές του παράγοντα-α νέκρωσης των όγκων (TNF-α) στη δυσλειτουργία και τη βλάβη του ενδοθηλίου των αγγείων σε ασθενείς με ρευματοειδή αρθρίτιδα
… to investigate whether long-term treatment with anti-TNFα agents can modulate vascular endothelial function and CCA-IMT in patients with rheumatoid arthritis (RA). Methods: 19 patients with RA on anti-TNFα treatment due to uncontrolled disease activity were prospectively studied. Patients more …
-
Μελέτη του πνευμονικού παρεγχύματος με υπολογιστική τομογραφία θώρακος υψηλής ευκρίνειας σε ασθενείς με ρευματοειδή αρθρίτιδα πριν και μετά τη θεραπεία με anti-TNF παράγοντες
… at baseline and after one-year οf treatment with anti-TNF agents AbstractIntroduction to Rheumatoid Arthritis Rheumatoid arthritis (RA) is a chronic, autoimmune systemic inflammatory disease. RA represents the most frequent inflammatory disease, affecting approximately 0.5-2% of the worldwide …
Page 1 of 2